학술논문
Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)
Document Type
Article
Author
Source
In: Oncology Research and Treatment . (Oncology Research and Treatment, 1 September 2016, 39(9):539-547)
Subject
Language
English
ISSN
22965262
22965270
22965270